Clinical Trial Update: Safety and Efficacy Study of 90Y-hPAM4 at Different Doses [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting safety and efficacy of 90Y-hPAM4 across Phase 1/Phase 2 in pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 90Y-hPAM4

Snippet

Sponsor: Gilead Sciences | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED